JP2023522193A5 - - Google Patents
Info
- Publication number
- JP2023522193A5 JP2023522193A5 JP2022562752A JP2022562752A JP2023522193A5 JP 2023522193 A5 JP2023522193 A5 JP 2023522193A5 JP 2022562752 A JP2022562752 A JP 2022562752A JP 2022562752 A JP2022562752 A JP 2022562752A JP 2023522193 A5 JP2023522193 A5 JP 2023522193A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20170255.2 | 2020-04-17 | ||
| EP20170255 | 2020-04-17 | ||
| PCT/GB2021/050940 WO2021209775A1 (en) | 2020-04-17 | 2021-04-19 | Antigen pool |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522193A JP2023522193A (ja) | 2023-05-29 |
| JPWO2021209775A5 JPWO2021209775A5 (https=) | 2024-05-20 |
| JP2023522193A5 true JP2023522193A5 (https=) | 2024-05-20 |
Family
ID=70333816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562752A Pending JP2023522193A (ja) | 2020-04-17 | 2021-04-19 | 抗原プール |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230302109A1 (https=) |
| EP (1) | EP4136096A1 (https=) |
| JP (1) | JP2023522193A (https=) |
| CN (1) | CN115667288A (https=) |
| CA (1) | CA3176754A1 (https=) |
| WO (1) | WO2021209775A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025202937A1 (en) | 2024-03-26 | 2025-10-02 | BioNTech SE | Cancer vaccines |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002515734A (ja) | 1996-01-02 | 2002-05-28 | カイロン コーポレイション | 遺伝子改変された樹状細胞により媒介される免疫刺激 |
| US6770456B1 (en) | 1998-07-29 | 2004-08-03 | Ludwig Institute For Cancer Research | Endogenous retrovirus tumor associated nucleic acids and antigens |
| EP1586330A1 (en) | 2004-04-16 | 2005-10-19 | Georg-August-Universität Göttingen | Vaccination against malignant melanoma |
| DK1871391T3 (da) | 2005-03-30 | 2012-04-16 | Viroxis | Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling |
| AT502292B1 (de) * | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US8921050B2 (en) | 2006-03-17 | 2014-12-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods of diagnosing renal cell carcinoma |
| US20080019979A1 (en) | 2006-05-22 | 2008-01-24 | Feng Wang-Johanning | HERV-K Antigens, Antibodies, and Methods |
| EP3576751A4 (en) * | 2017-02-01 | 2021-08-04 | ModernaTX, Inc. | RNA ANTI-CANCER VACCINES |
| BR112021006941A2 (pt) * | 2018-10-19 | 2021-08-31 | The Francis Crick Institute Limited | Antígenos de câncer inovadores e métodos |
| AU2020302285A1 (en) * | 2019-06-28 | 2021-12-02 | Enara Bio Limited | Novel cancer antigens and methods |
| WO2021005338A2 (en) * | 2019-07-05 | 2021-01-14 | The Francis Crick Institute Limited | Novel cancer antigens and methods |
| CN116057067A (zh) * | 2020-04-17 | 2023-05-02 | 弗朗西斯·克里克研究所有限公司 | 用于治疗黑素瘤的ctl抗原的融合蛋白 |
-
2021
- 2021-04-19 JP JP2022562752A patent/JP2023522193A/ja active Pending
- 2021-04-19 CN CN202180029092.4A patent/CN115667288A/zh active Pending
- 2021-04-19 WO PCT/GB2021/050940 patent/WO2021209775A1/en not_active Ceased
- 2021-04-19 EP EP21721983.1A patent/EP4136096A1/en active Pending
- 2021-04-19 CA CA3176754A patent/CA3176754A1/en active Pending
-
2022
- 2022-10-14 US US18/046,670 patent/US20230302109A1/en active Pending